Dr. Xiao Xu receives grant funding from the National Institute on Minority Health and Health Disparities (R01MD016386), Agency for Healthcare Research and Quality (R01HS028612), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD098287 and R01HD087425), and the National Heart, Lung, and Blood Institute (R01HL151603).

Dr. Joseph Ross received financial support from the National Heart, Lung, and Blood Institute, NIH (Grant No. R01 HL 144644-01). Ross also currently receives research support through Yale University from Johnson & Johnson to develop methods of clinical trial data sharing; from the Medical Device Innovation Consortium as part of the National Evaluation System for Health Technology; from the Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation program (Grant No. U01FD005938); from the Agency for Healthcare Research and Quality (Grant No. R01HS022882); from the National Heart, Lung, and Blood Institute, NIH (Grants Nos. R01HS025164 and R01HL144644); and from Arnold Ventures to establish the Good Pharma Scorecard at Bioethics International. In addition, Ross is an expert witness at the request of Relator’s attorneys, the Greene Law Firm, in a qui tam suit alleging violations of the False Claims Act and Anti-Kickback Statute against Biogen Inc.

Dr. Erica Spatz receives grant funding from the Centers for Disease Control and Prevention (20042801-Sub01), the National Institute on Minority Health and Health Disparities (U54MD010711-01), the U.S. Food and Drug Administration to support projects within the Yale-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI, U01FD005938), the National Institute of Biomedical Imaging and Bioengineering (R01 EB028106-01), and the National Heart, Lung, and Blood Institute (R01HL151240).

Dr. Nihar Desai is under contract with the Centers for Medicare and Medicaid Services to develop and maintain performance measures used for public reporting and pay for performance programs. He also reports research grants and consulting for Amgen, Astra Zeneca, Boehringer Ingelheim, Cytokinetics, MyoKardia, Relypsa, Novartis, and SCPharmaceuticals.